| Literature DB >> 35956075 |
Jing Ma1,2,3, Yaping Yuan4,5, Li Zhang1,2,3, Shizhen Chen4,5,6, Haiyan Cao1,2,3, Liu Hong1,2,3, Juanjuan Liu1,2,3, Xiaoyan Song1,2,3, Jiawei Shi1,2,3, Yi Zhang1,2,3, Li Cui1,2,3, Xin Zhou4,5,6, Mingxing Xie1,2,3.
Abstract
Right ventricular (RV) function is one of the critical factors affecting the prognosis of fetuses with hypoplastic left heart syndrome (HLHS). Our study objectives included assessment of cardiac function and comprehensive measurement of cardiac microstructure. We retrospectively studied 42 fetuses diagnosed as HLHS by echocardiography. Myocardial deformation of the right ventricular wall was calculated automatically in offline software. Postmortem cardiac imaging for three control fetal hearts and four HLHS specimens was performed by a 9.4T DTI scanner. Myocardial deformation parameters of the RV (including strain, strain rate, and velocity) were significantly lower in HLHS fetuses (all p < 0.01). FA values increased (0.18 ± 0.01 vs. 0.21 ± 0.02; p < 0.01) in HLHS fetuses, but MD reduced (1.3 ± 0.15 vs. 0.88 ± 0.13; p < 0.001). The HLHS fetuses' RV lateral base wall (-7.31 ± 51.91 vs. -6.85 ± 31.34; p = 0.25), middle wall (1.71 ± 50.92 vs. -9.38 ± 28.18; p < 0.001), and apical wall (-6.19 ± 46.61 vs. -11.16 ± 29.86, p < 0.001) had HA gradient ascent but HA gradient descent in the anteroseptal wall (p < 0.001) and inferoseptal wall (p < 0.001). RV basal lateral wall HA degrees were correlated with RVGLS (R2 = 0.97, p = 0.02). MD values were positively correlated with RVGLS (R2 = 0.93, p = 0.04). Our study found morphological and functional changes of the RV in HLHS fetuses, and cardiac function was related to the orientation patterns of myocardial fibers. It may provide insight into understanding the underlying mechanisms of impaired RV performance in HLHS.Entities:
Keywords: cardiac diffusion tensor imaging; fetal echocardiography; hypoplastic left heart syndrome; myocardial microstructural; right ventricular function
Year: 2022 PMID: 35956075 PMCID: PMC9369849 DOI: 10.3390/jcm11154456
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Cohort characteristics.
| Variable | Control Group | HLHS Group | |
|---|---|---|---|
| Maternal characteristic | |||
| Age (years) | 30.00 ± 5.07 | 29.45 ± 5.46 | 0.40 |
| BMI (kg/m2) | 24.67 ± 3.34 | 23.40 ± 3.01 | 0.15 |
| Gestational Age (weeks) | 24.67 ± 3.34 | 24.49 ± 3.88 | 0.31 |
| Obstetric history | |||
| Gravidity | 2(1–3) | 3(2–5) | <0.01 |
| Parity | 1(0–2) | 1(0–1) | 0.05 |
| Abortion | 0(0–2) | 1(0–2) | 0.36 |
| Anatomical variants | |||
| Mitral atresia (MA)/aortic atresia (AA) | 11(26.20%) | ||
| Mitral stenosis (MS)/AA | 6(14.29%) | ||
| MS/aortic stenosis (AS) | 10(23.81%) | ||
| Hypoplastic left heart complex (HLHC) | 15(35.71%) | ||
| LV morphology | |||
| silt-like | 15(35.71%) | ||
| miniature | 25(59.52%) | ||
| Dilation | 2(4.76%) |
Continuous variables were expressed as the mean ± standard deviation or the median (interval between quartiles); categorical data were expressed as number (%). BMI, body Mass Index.
Fetal left and right heart dimensions and hemodynamics in HLHS fetuses and normal fetuses at 23~30 gestational weeks.
| Variable | Control Group | HLHS Group | |
|---|---|---|---|
| (n = 42) | (n = 42) | ||
| Morphometric measurements | |||
| RVGSI | 0.58 ± 0.08 | 0.71 ± 0.15 | <0.01 |
| LVGSI | 0.49 ± 0.05 | 0.52 ± 0.15 | 0.02 |
| LVEDD (cm) | 0.95 (0.83 to 1.02) | 0.56 (0.35 to 0.72) | <0.001 |
| LVEDD z-score | 0.42 (−0.13 to 0.83) | −3.51 (−5.58 to −2.1) | <0.001 |
| LVEDL (cm) | 1.92 (1.83 to 2.04) | 1.04 (0.69 to 1.4) | <0.001 |
| LVEDL z-score | 0.06 (−0.24 to 0.87) | −4.34 (−6.5 to −2.88) | <0.001 |
| RVEDD (cm) | 0.97 (0.9 to 1.05) | 1.10 (0.92–1.19) | 0.02 |
| RVEDD z-score | 0.04 (−0.27 to 0.51) | 0.66 (−0.34 to 1.75) | 0.04 |
| RVEDL (cm) | 1.72 (1.57 to 1.83) | 1.61 (1.34 to 1.74) | 0.14 |
| RVEDL z-score | −0.03 (−0.58 to 0.24) | −0.83 (−1.64 to −0.23) | <0.01 |
| FO (cm) | 0.48 ± 0.09 | 0.41 ± 0.15 | 0.03 |
| PV z-score | 0.19 (−0.47 to 0.97) | 0.41 (−0.47 to 1.09) | 0.69 |
| Main PA z-score | 0.65 (0.1 to 1.06) | 0.89 (0.26 to 1.34) | 0.12 |
| LPA z-score | 0.29 (−0.08 to 0.61) | −0.35 (−1.07 to 0.05) | <0.001 |
| RPA z-score | 0.12 (−0.39 to 0.57) | −0.56 (−1.21 to −0.06) | <0.001 |
| DA z-score | −0.12 (−0.41 to −0.12) | 0.62 (−0.29 to 1.04) | <0.001 |
| AAo z-score | 0.09 (−0.28 to 0.43) | −3.21 (−4.89 to −2.41) | <0.001 |
| AV z-score | 0.08 (−0.38 to 0.60) | −3.1 (−4.38 to −2.18) | <0.001 |
| Hemodynamic Measurements | |||
| Pulmonary artery | |||
| Peak systolic velocity (cm/s) | 70.3 ± 17.78 | 77.24 ± 14.96 | 0.14 |
| Ductus arteriosus | |||
| Peak systolic velocity (cm/s) | 93.21 ± 22.99 | 96.51 ± 20.44 | 0.84 |
| Ascending aorta | |||
| Peak systolic velocity (cm/s) | 94.43 ± 10.23 | 111.15 ± 49.45 | 0.04 |
| FHR (bmp) | 148.77 ± 7.07 | 147.37 ± 6.05 | 0.18 |
Values are expressed as mean ± SD or median (interquartile range); LVEDD z-score, left ventricular end diastolic diameter z-score; RVEDD z-score, right ventricular end diastolic diameter z-score; LVEDL z-score, left ventricular end diastolic length z-score; RVEDL z-score, right ventricular end diastolic length z-score; FO, foramen ovale; AAo, ascending aorta; AV, aortic valve; MPA, main pulmonary artery; PV, pulmonary valve; LPA, left pulmonary artery; RPA right pulmonary artery; DA, ductus arteriosus; GSI, global sphericity index; GA, gestational weeks. p-value means comparing the HLHS group with control group.
Fetal right ventricle myocardial deformation by a two-dimensional speckle tracking echocardiography in HLHS fetuses and normal fetuses at 23~30 gestational weeks.
| Variable | Control Group | HLHS Group | |
|---|---|---|---|
| Systolic Function | |||
| RVGLS (%) | −21.60 (−22.32 to −19.99) | −15.58 (−18.33 to −13.87) | <0.001 |
| RVGLVs (cm/s) | −1.75 (−2.94 to −1.58) | −1.50 (−2.20 to −1.00) | 0.02 |
| RVGLSRs ( | −1.95 (−2.45 to −1.65) | −1.40 (−1.68 to −1.20) | <0.01 |
| Diastolic Function | |||
| RVGLDd (mm) | 1.90 (1.42 to 2.68) | 1.20 (0.89 to 1.60) | <0.001 |
| RVGLVd (cm/s) | 1.60 (1.28 to 2.45) | 0.95 (0.70 to 1.50) | <0.001 |
| RVGLSRd ( | 2.05 (1.40 to 2.43) | 1.80 (1.25 to 2.15) | 0.10 |
Values are expressed as the mean ± SD or median (interquartile range); RVGLS, right ventricle global longitudinal strain; RVGLV, right ventricle global longitudinal velocity; RVGLD, right ventricle global longitudinal displacement; RVGLSR, right ventricle global longitudinal strain rate. p-value means comparing the HLHS group with the control group.
Univariate regression analysis for RV myocardial deformation parameters in HLHS fetuses.
| Variable | RVGLS | 95% CI | |
|---|---|---|---|
| β | |||
| GA (weeks) | 0.03 | 0.85 | 0.19–0.85 |
| RVEDD z-score | −0.26 | 0.12 | −1.55–0.19 |
| RVEDL z-score | 0.15 | 0.38 | −0.53–1.34 |
| RVEDD/LVEDD | −0.48 * | 0.01 | −1.81 to −0.25 |
| RVGSI | −0.24 | 0.14 | −12.14 to 1.81 |
| LVEDD z-score | 0.37 * | 0.03 | 0.06–0.92 |
| LVEDL z-score | 0.32 | 0.06 | −0.02–0.75 |
| LVGSI | 0.079 | 0.64 | −0.58–9.33 |
| FO (cm) | −0.14 | 0.43 | −9.69–4.18 |
| LPA z-score | −0.21 | 0.21 | −2.33–0.52 |
| RPA z-score | −0.20 | 0.24 | −2.47–0.65 |
| DA z-score | −0.13 | 0.45 | −1.51–0.68 |
| AAo z-score | 0.39 * | 0.02 | 0.05–0.69 |
| AV z-score | 0.36 | 0.06 | −0.02–0.89 |
LVEDD z-score, left ventricular end diastolic diameter z-score; RVEDD z-score, right ventricular end diastolic diameter z-score; LVEDL z-score, left ventricular end diastolic length z-score; RVEDL z-score; right ventricular end diastolic length z-score; AAo, ascending aorta; AV, aortic valve; MPA, main pulmonary artery; PV, pulmonary valve; LPA, left pulmonary arter; RPA right pulmonary artery; DA, ductus ateriosus; GSI, global sphericity index; FO, foramen ovale; GA, gestational weeks. CI, confidence interval. * p < 0.05.
Multivariate regression analysis for RV myocardial deformation parameters in HLHS fetuses.
| RVGLS | |||
|---|---|---|---|
| Variable | β |
| 95% CI |
| RVEDD/LVEDD | 0.06 | 0.90 | |
| AAo z-score | 0.20 | 0.34 | |
| LVEDD z-score * | 0.48 | 0.02 | 0.08–1.01 |
LVEDD z-score, left ventricular end diastolic diameter z-score; AAo, ascending aorta; RVEDD/LVEDD, ratio of right ventricular end diastolic diameter and left ventricular end diastolic diameter; CI, confidence interval. * p <0.05.
Figure 1Correlation between RVGLS and LVEDD z-score. RVGLS, right ventricle global longitudinal strain; LVEDD z-score, left ventricular end diastolic dimension z-score.
Figure 2(A) FA map in normal fetuses. (B) FA map in HLHS fetuses. (C) FA values increased in HLHS fetuses.
Right ventricular myocardial microstructure dynamics in HLHS and control specimens at 24~30 gestational weeks.
| Variable | Control | HLHS | HLHS | |
|---|---|---|---|---|
| FA | 0.18 ± 0.01 | 0.21 ± 0.02 | 0.3 ± 0.04 | <0.01 |
| MD (×10−3, mm2·s−1) | 1.3 ± 0.15 | 0.88 ± 0.13 | 0.74 ± 0.06 | <0.001 |
Acquired by diffusion tension cardiovascular magnetic resonance technology. FA, fractional anisotropy, MD, mean diffusivity. p-values were compared with normal fetuses with HLHS fetuses.
Figure 3(A) MD map in normal fetuses. (B) MD map in HLHS fetuses. (C) MD values decreased in HLHS fetuses.
Regional characteristics of the helix angle gradient in the right ventricle in HLHS and control specimens at 24~30 gestational weeks.
| Variable | Control | HLHS | HLHS | |
|---|---|---|---|---|
| Basal | ||||
| lateral | −6.85 ± 31.34 | −7.31 ± 51.91 | −4.77 ± 35.36 | 0.25 |
| anteroseptal | 12.89 ± 36.06 | 1.2 ± 54.31 | −21.43 ± 27.59 | <0.001 |
| inferoseptal | −21.75 ± 31.63 | 2.54 ± 53.46 | 29.87 ± 34.93 | <0.001 |
| Middle | ||||
| lateral | −9.38 ± 28.18 | 1.71 ± 50.92 | −6.07 ± 34.07 | <0.001 |
| anteroseptal | 23.29 ± 36.59 | −1.54 ± 41.38 | −24.96 ± 25.05 | <0.001 |
| inferoseptal | −14.37 ± 41.38 | 1.73 ± 61.31 | −14.94 ± 45.58 | <0.001 |
| Apical | ||||
| lateral | −11.16 ± 29.86 | −6.19 ± 46.61 | −7.53 ± 36.17 | <0.001 |
| anteroseptal | 27.19 ± 33.72 | −19.04 ± 23.58 | ||
| inferoseptal | 17.06 ± 39.39 | −32.85 ± 39.29 |
Acquired by diffusion tension cardiovascular magnetic resonance technology. HA, helix angle; p-values were compared with normal fetuses with HLHS fetuses.
Figure 4(A,B) Whole heart fiber tracking in a normal fetus. (A) from ventral view, (B) from apical view. (D,E) the whole heart fiber tracking in an HLHS fetus D from ventral view and (E) from apical view. (C) HA map in normal fetus. (F) HA map in HLHS fetus.
Figure 5(A) HA gradient in normal fetus. (B) HA gradient in HLHS fetus. (C) HA gradient in an HLHS fetus with LV dilation.
Figure 6(A) Correlation between MD and RVGLS (%) in HLHS fetuses. (B) Correlation between HA degrees of the right ventricle basal lateral wall and RVGLS (%) in HLHS fetuses.